### ğŸ« Critical Care Medicine: Malignant Hyperthermia

#### âœ… True Statements
1. **Malignant hyperthermia** is caused by a rare **autosomal dominant derangement in intracellular calcium metabolism**.
2. **Malignant hyperthermia** is triggered by **inhaled anesthetics** (such as **halothane** and **isoflurane**) or the **depolarizing paralytic succinylcholine**.
3. Signs and symptoms of **malignant hyperthermia** reflect **hypermetabolism** and include **severe elevation in core body temperature**, **muscle rigidity**, **tachycardia**, and **tachypnea**.
4. **Malignant hyperthermia** can present with **cardiac arrhythmias** and **rhabdomyolysis**, which may be reflected by **elevated creatine kinase**, **hyperkalemia**, and **hyperphosphatemia**.
5. **Mortality from malignant hyperthermia** can reach **10%**.
6. Treatment of **malignant hyperthermia** includes **discontinuing the triggering agent**, **active cooling**, and **administration of dantrolene** every **5 to 10 minutes** until **muscle rigidity** and **hyperthermia resolve**.

#### ğŸ’¬ Extra
1. Dantrolene is a skeletal muscle relaxant that reduces calcium release from the sarcoplasmic reticulum, reversing hypermetabolism.
2. Elevated potassium and phosphate levels occur secondary to muscle breakdown from rhabdomyolysis.

#### ğŸ·ï¸ Tags
#CriticalCare #MalignantHyperthermia #Anesthesiology #CalciumMetabolism #Dantrolene #Rhabdomyolysis

#### ğŸ“š Reference
Litman RS, Smith VI, Larach MG, et al. Consensus statement of the Malignant Hyperthermia Association of the United States on unresolved clinical questions concerning the management of patients with malignant hyperthermia. *Anesth Analg*. 2019;128:652-9. PMID: 30768455 doi:10.1213/ANE.0000000000004039

#### ğŸ†” Question ID
CCMCQ24007

#### ğŸ•’ Last Updated
February 2025

---

#### ğŸ“– Related Text
MKSAP 19: Critical Care Medicine â€” Specific Critical Care Topics, Hyperthermic Emergencies, Malignant Hyperthermia

---

### ğŸ“˜ Related Text Derivations

#### âœ… True Statements
1. **Malignant hyperthermia** can cause core body temperature to reach **45.0 Â°C (113.0 Â°F) or greater**.
2. Laboratory findings in **malignant hyperthermia** may show **elevated serum creatine kinase**, **potassium**, and **phosphate levels** consistent with **rhabdomyolysis**.
3. Treatment of **malignant hyperthermia** includes **intravenous fluids** and **ice packs** in addition to discontinuing the trigger and giving **dantrolene**.

#### ğŸ’¬ Extra
1. The extreme hyperthermia is a hallmark that differentiates malignant hyperthermia from many other hyperthermic emergencies.
3. Cooling strategies are essential supportive measures to reduce morbidity and mortality.

#### ğŸ·ï¸ Tags
#CriticalCare #Hyperthermia #MalignantHyperthermia #Rhabdomyolysis #Dantrolene
